---
title: "Citigroup raised the target stock price of Thermo Fisher Scientific from $500 per share to $580"
description: "Citigroup raised the target stock price of Thermo Fisher Scientific from $500 per share to $580"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262419473.md"
published_at: "2025-10-23T11:31:00.000Z"
---

# Citigroup raised the target stock price of Thermo Fisher Scientific from $500 per share to $580

Citigroup raised the target stock price for Thermo Fisher Scientific from $500 per share to $580

### Related Stocks

- [TMO.US - Thermo Fisher Scentific](https://longbridge.com/en/quote/TMO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| QXO, Apollo Global, Thermo Fisher Scientific And More On CNBC's 'Final Trades' | On CNBC's 'Halftime Report Final Trades', QXO, Inc. was highlighted as a top pick after its shares rose 4.4% to $27.07.  | [Link](https://longbridge.com/en/news/276125837.md) |
| Citigroup Says Signed And Closed The Sale Of AO Citibank, Citi’S Former Russian Subsidiary, To Renaissance Capital | Feb 18 (Reuters) - Citigroup Inc:CITIGROUP: SIGNED AND CLOSED THE SALE OF AO CITIBANK, CITI’S FORMER RUSSIAN SUBSIDIARY, | [Link](https://longbridge.com/en/news/276234739.md) |
| Citigroup exits Russia after sale of former subsidiary | Feb 18 (Reuters) - Citigroup announced the sale of its former Russian subsidiary, AO Citibank, to Renaissance Capital on | [Link](https://longbridge.com/en/news/276236164.md) |
| Former Citigroup unit in Russia says it is changing its name to RenCap Bank | Feb 13 (Reuters) - Citigroup’sformer Russian unit, AO Citibank, said on Friday it would change its name to RenCap Bank f | [Link](https://longbridge.com/en/news/275901701.md) |
| Fortrea (FTRE) Expected to Announce Earnings on Thursday | Fortrea (NASDAQ:FTRE) is set to announce its Q4 2025 earnings on February 26, with expectations of $0.16 per share and $ | [Link](https://longbridge.com/en/news/276315176.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.